Redsense Medical (Sweden) Price Prediction
| REDS Stock | SEK 7.16 0.08 1.13% |
Oversold Vs Overbought
49
Oversold | Overbought |
Using Redsense Medical hype-based prediction, you can estimate the value of Redsense Medical AB from the perspective of Redsense Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Redsense Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Redsense because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Redsense Medical after-hype prediction price | SEK 7.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Redsense |
Redsense Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Redsense Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Redsense Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Redsense Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Redsense Medical Estimiated After-Hype Price Volatility
In the context of predicting Redsense Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Redsense Medical's historical news coverage. Redsense Medical's after-hype downside and upside margins for the prediction period are 2.75 and 11.57, respectively. We have considered Redsense Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Redsense Medical is moderately volatile at this time. Analysis and calculation of next after-hype price of Redsense Medical is based on 3 months time horizon.
Redsense Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Redsense Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Redsense Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Redsense Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.17 | 4.41 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.16 | 7.16 | 0.00 |
|
Redsense Medical Hype Timeline
Redsense Medical is at this time traded for 7.16on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Redsense is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.17%. %. The volatility of related hype on Redsense Medical is about 0.0%, with the expected price after the next announcement by competition of 7.16. The company recorded a loss per share of 0.63. Redsense Medical had not issued any dividends in recent years. Assuming the 90 days trading horizon the next anticipated press release will be within a week. Check out Redsense Medical Basic Forecasting Models to cross-verify your projections.Redsense Medical Related Hype Analysis
Having access to credible news sources related to Redsense Medical's direct competition is more important than ever and may enhance your ability to predict Redsense Medical's future price movements. Getting to know how Redsense Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Redsense Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GETI-B | Getinge AB ser | 0.00 | 0 per month | 0.00 | (0.30) | 1.60 | (3.85) | 6.56 | |
| ALIF-B | AddLife AB | 0.00 | 0 per month | 0.00 | (0.18) | 2.37 | (3.42) | 14.89 | |
| BIOT | Biotage AB | 0.00 | 0 per month | 0.00 | (0.19) | 3.06 | (4.27) | 9.07 | |
| BONEX | Bonesupport Holding AB | 0.00 | 0 per month | 2.65 | 0.08 | 4.52 | (3.73) | 11.23 | |
| FLUO | Fluoguide AS | 0.00 | 0 per month | 0.00 | (0.05) | 5.36 | (4.45) | 14.84 |
Redsense Medical Additional Predictive Modules
Most predictive techniques to examine Redsense price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Redsense using various technical indicators. When you analyze Redsense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Redsense Medical Predictive Indicators
The successful prediction of Redsense Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Redsense Medical AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Redsense Medical based on analysis of Redsense Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Redsense Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Redsense Medical's related companies.
Story Coverage note for Redsense Medical
The number of cover stories for Redsense Medical depends on current market conditions and Redsense Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Redsense Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Redsense Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Redsense Stock Analysis
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.